Evidence map›Paper›PMID 42415357›Full record

ArticleStatistics in medicine2026

Checking Genetic Homogeneity Between Two Samples Using Summary Statistics With Application to Mendelian Randomization.

Kai Wang, Grace Z Wang

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kai WangDepartment of Biostatistics, University of Iowa, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0002-3229-9866
Grace Z WangDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Collaborative GWAS of Dementia, AD and related MRI and Cognitive EndophenotypesR01AG033193 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SESHADRI, SUDHA · 2009 to 2016
$4.4M
AGES N01-AG-12100Alzheimer's Association ADGC-10-196728Alzheimer's Research UK n° 503176Competence Network Dementia 01GI0420Competence Network Dementia 01GI0711Competence Network Dementia n° 01GI0102Medical Research Council n° 503480NHLBI NIH HHS R01 HL105756NIA NIH HHS R01 AG033193NIA NIH HHS U01 AG016976NIA NIH HHS U01 AG032984NIA NIH HHS U24 AG021886NIEHS NIH HHS P30 ES005605NIH/NIA NIA AG081220Wellcome Trust n° 082604/2/07/Z
6 · The paper itself

Abstract

backgroundA common assumption in two-sample summary-data Mendelian randomization (MR) studies is that the effect of an instrumental single nucleotide polymorphism (SNP) on both the exposure and the outcome is consistent across the exposure and outcome samples. This assumption is more likely to hold when the minor allele frequency (MAF) of the instrumental SNP is similar in the two samples. However, in the common situation where MAF information is unavailable, there is currently no formal method to assess this condition, apart from heuristically matching the ethnic backgrounds of the exposure and outcome samples.

methodWe propose a simple method to assess whether the genetic variance of a SNP, which is uniquely determined by its minor allele frequency (MAF) under Hardy-Weinberg equilibrium, is the same across two genome-wide association studies (GWASs). The method is motivated by the observation that, in linear-model GWASs, although the absolute magnitude of a SNP's variance cannot be recovered from summary statistics, its variance relative to that of other SNPs can be inferred. This observation continues to hold approximately when the underlying model is nonlinear.

resultsWe propose a V-V plot and a modified Bland-Altman plot to identify SNPs that have different genetic variances between two GWASs. Some published two-sample summary-data MR studies, unfortunately, seem to include SNPs that are not genetically homogeneous.

conclusionsThe proposed method provides a useful tool for enhancing the quality of a two-sample summary-data MR study. We advocate checking for equality of SNP MAFs between the exposure and the outcome GWASs before conducting a two-sample summary-data MR analysis, and our proposed method serves this purpose when the MAF information is missing in at least one of the two GWASs.

Indexed as

Genome-Wide Association StudyMendelian Randomization AnalysisPolymorphism, Single NucleotideComputer SimulationGene FrequencyHumansLinear ModelsModels, GeneticModels, Statisticalgenetic homogeneityGWASlinear regressionMendelian randomizationsummary statistics

Identifiers

PMID42415357
PMCPMC13342494

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.